)--Linking the Frontiers of Technology, Serving Business InnovationJuly 10 News: At the recent Aegean Retina Conference held in Greece, a company named Ocutrx Vision showcased an AR glasses product with vision adjustment capabilities: Oculenz ARwear. According to the company, it is the only solution on the market that can help patients with age-related macular degeneration restore their vision.
Reportedly, Oculenz features a split design characterized by its lightweight build (under 200g), wide field of view (110°), support for 6DoF head tracking, and 2.5K resolution. It is equipped with two HD cameras, five camera sensors, noise-canceling microphones, and spatial audio headphones. Additionally, it includes a detachable module, resembling an electronic leash pack, which houses the control panel and battery and supports independent charging. Regarding the optical solution, Ocutrx has not disclosed specific details.
Oculenz Visual Virtual Assistant
Oculenz also supports eye tracking (USPTO patent pending), which can be used not only for foveated rendering but also to monitor users’ eye fatigue levels. Additionally, it can detect signs of poisoning or drug influence through pupil analysis and issue alerts, making it suitable for deployment on production lines to help monitor and manage worker safety. The system also features gesture recognition (supporting up to 27 degrees of freedom), a voice assistant, a visual virtual assistant (with customizable avatars such as male, female, gender-neutral, or cartoon characters), object recognition, and simultaneous localization and mapping (SLAM).
In terms of applications, Oculenz can function as an external display, allowing you to stream any application from connected devices—such as calling apps, videos, and games (including LBS AR games)—to the glasses. You can connect it directly to smartphones, tablets, or laptops via mini-HDMI or USB-C cables, or opt for wireless connectivity through Bluetooth and Wi-Fi. Furthermore, Oculenz features an open developer platform that supports applications across various sectors, including healthcare, gaming, industrial, military (integrated with military helmets), shopping, B2B, B2C, and drones.
It is understood that Ocutrx’s AR glasses-related patents have been approved by the United States Patent and Trademark Office, including the design and concept of the Oculenz AR headset, as well as a sophisticated algorithm that clarifies the visual field for patients with macular degeneration by adjusting video pixels.
Michael H.Freeman
Qingting.com learned from the official website of Ocutrx that the inventor of its AR glasses technology is Dr. Michael H. Freeman, an Emmy Award winner who also claims to be the inventor of mobile video.
Ocutrx glasses are now available for pre-order, priced at $6,000 (more expensive than Magic Leap One and HoloLens), with a discounted price of $4,500. For an AR headset, this pricing is quite high; however, compared to other AR headsets on the market, its positioning is broader, as it can serve both B-end and C-end users while also helping patients with visual impairments see more clearly. Furthermore, the pricing reflects the company’s confidence in the AR market.
This article is translated by Qingting Network from:GlobalNewswire，Oculenz